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A 37-year-old woman had a urinary tract infection in July 2009 
that was successfully treated by antibiotics but resulted in diarrhea. 
She was placed on a probiotic diet and then became aware, during the 
same month, of persistent and widespread, bilateral oral lesions. The 
lesions on the tongue were somewhat painful and she was given 
miracle mouthwash for symptomatic relief. She denied dysphagia, 
odynophagia, neck swelling or masses, headaches, visual problems, 
skin lesions, or otalgia. She also denied tobacco or alcohol abuse. 
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Clinical examination revealed diffuse involvement of the oral 
cavity with striated white lesions and areas of erosion and shallow 
ulceration. A distinct reticular pattern was noted on the lower labial 
mucosa. Erosive lichen planus was a prime consideration in this case 
due to the distribution and clinical appearance of the lesions. Lichen 
planus is a common condition of unknown etiology but believed to be 
immune mediated, can affect both the skin and oral mucosa. It 
develops primarily in middle-aged adults, and females are affected 
more often than males. Lesions can present bilaterally on the posterior 
buccal mucosa, but other oral sites such as the tongue, gingiva, lips, 
and palate may also be involved. The lesions of erosive lichen planus 
appear erythematous, often with central ulceration. Fine white striae 
are classically observed around the periphery of the ulcers. 
Several other immunologic and allergic conditions can present 
with a clinical pattern similar to lichen planus including lupus 
erythematosus, chronic ulcerative stomatitis, erythema multiforme and 
graft-versus-host disease. The history of lesions developing while the 
patient was on a probiotic diet raises suspicion for the possibility of an 
allergic mucosal reaction to diet but it may also related to systemic 
antibiotics. Probiotics are commonly used to treat antibiotic-associated 
diarrhea which was the most probable scenario in the present case. 
They are available in the form of foods and dietary supplements and 
are not regulated by the Food and Drug Administration. Drug reactions 
of the oral mucosa can have a variety of clinical appearances, including 
lichenoid and lupus-like patterns. While probiotics have not been 
specifically implicated in mucosal drug reactions, the nature and 
composition of the patient’s diet were unknown. Resolution of lesions 
would be expected with discontinuation of the potentially offending 
agent. 
Chronic ulcerative stomatitis (CUS) is a rare and recently-
described immune-mediated condition that also deserves consideration 
in this case. Erosions and ulcerations of the tongue and buccal mucosa 
are common. Irregular red and white areas typically surround the 
ulcers, but defined striae may not be present. Similar to erosive lichen 
planus, CUS may also present as a desquamative gingivitis. The 
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disease predominates among females in the sixth decade [1] which is 
a slightly older population when compared to lichen planus. Since CUS 
usually responds best to Plaquenil, an incisional biopsy with direct 
immunofluorescence is recommended for erosive lichenoid processes, 
especially cases that are unresponsive to corticosteroids. 
Lupus erythematosus (LE) is a common, multisystem, 
immunologic condition that can present with a variety of oral 
manifestations. Systemic lupus erythematosus (SLE) is the most 
serious form of the disease due to the potential for kidney 
involvement, which can eventually progress to renal failure. 
Cutaneous, musculoskeletal, neurologic, and cardiac involvement are 
also common. Oral lesions may be seen in up to 40% of patients [1]. 
The average age at diagnosis is 31 and women are affected 8–
10 times more often than men [1]. Chronic cutaneous lupus 
erythematosus (CCLE) is a much less severe form of LE that is usually 
limited to the skin and oral mucosa. A third form, subacute cutaneous 
lupus erythematosus (SCLE), has clinical overlap between SLE and 
CCLE. Oral lesions of LE may be lichenoid, granulomatous, or 
nonspecific in appearance. Typical anatomic locations affected include 
the buccal mucosa, palate, gingiva, and occasionally the lower lip. 
Given the age and sex of the patient, as well as the clinical appearance 
and distribution of the oral lesions, LE is another logical consideration 
in the differential diagnosis of this case. 
Diagnosis and Discussion 
The patient in the current case was diagnosed with AML-M4 
(acute myelogenous leukemia) in February of 2006 with normal 
cytogenetics. The leukemia was initially treated with induction 
chemotherapy followed by a HLA-matched BMT (human leukocyte 
antigen matched bone marrow transplant) from a sibling donor in July 
of 2006. She suffered from several opportunistic infections following 
the transplant, including Coag (−) Staphylococcus bacteremia, 
Acinetobacter bacteremia, AFB (acid fast bacillus) infection, 
Pseudomonas aeruginosa and Proteus mirabilis. The patient achieved 
remission following the transplant but developed graft-versus-host 
disease (GVHD) limited to the upper gastrointestinal tract area which 
was managed with photopheresis. She received re-induction 
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chemotherapy with clofarabine and high dosage Ara-C after a relapse 
in the summer of 2007, which was followed by consolidation therapy 
with high dose Ara-C and idarubicin in September of 2007. This was 
then followed by a match-unrelated stem cell transplant, treatment 
with fludarabine and total body irradiation conditioning in November 
2007. She again developed several opportunistic infections in July of 
2009, including Coag (−) Staph bacteremia, cholecystitis, pancreatitis 
secondary to Diazide diuretics, and herpes labialis. The herpes labialis 
was initially resistant to Valtrex and acyclovir but was subsequently 
responsive to cidofovir. In July 2009, she developed generalized oral 
lesions with a lichenoid pattern on the gingiva, upper and lower labial 
mucosa, bilateral buccal mucosa, right and left lateral tongue, and 
posterior palate (Figs. 1, ,2).2). Her oral lesions were erosive in some 
areas. The tongue, which also exhibited a reticular pattern, displayed 
erosive areas and the patient experienced prominent glossodynia. 
Cytology smears obtained for fungal identification, as well as fungal 
cultures, were persistently negative. There was only limited relief with 
topical antifungal and magic mouth rinses (comprised of 80 ml viscous 
lidocaine 2%, 80 ml Mylanta and 80 ml diphenhydramine 12.5 mg per 
5 ml elixir). A superficial tongue biopsy performed in September 2009 
revealed parakeratosis, but was essentially inconclusive since the 
sample did not contain any lamina propria. This was followed by a 
biopsy of the lower lip mucosa which was diagnostic of the patient’s 
condition, demonstrating mild keratosis with paucicellular interface 
mucositis and marked epitheliotropism. Scattered apoptotic bodies 
were detected at the basal layer of the epithelium. The lamina propria 
supported a patchy mononuclear inflammatory cell infiltrate including 
few macrophages. The histomorphological features were consistent 
with graft-versus-host disease (Figs. 3, ,4).4). The patient was treated 
with prednisolone syrup 15 mg/5 ml with instructions to rinse and 
swallow for 2 min with 1 teaspoonful qid. The tongue symptoms 
resolved and her lesions showed significant improvement. 
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Fig. 1: Generalized leukoplakia and shallow ulcerations were noted on the 
maxillary and mandibular gingiva (a–c) and hard palate (d) (Note the 
reticular pattern seen in the palatal lesions) 
 
 
Fig. 2: Striated white lesions and ulcerations were noted on the right and 
left lateral tongue (a, b). The dorsal tongue (c) was affected at the anterior 
and lateral aspects. A well-defined reticular pattern was also evident on the 
lower lip mucosa (d) 
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Fig. 3: Biopsy of the lower lip mucosa revealed a paucicellular interface 
lichenoid inflammatory cell infiltrate. Periductal mononuclear inflammatory 
cell infiltrate was also seen in the labial minor salivary glands. (arrow, insert) 




Fig. 4: A high power view of the histomorphology of the lower lip biopsy 
showing prominent epitheliotropism and several apoptotic bodies identified in 
the basal layer of the epithelium (arrows). The lamina propria contained a 
mononuclear inflammatory cell infiltrate and scattered macrophages 
(Hematoxylin and eosin stain original magnification 40×) 
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GVHD is serious complication that occurs in recipients of allogenic 
hematopoietic stem cell transplantation, non-irradiated blood 
transfusions, or transplacental lymphocyte transfusion to an 
immunodeficient fetus. Bone marrow transplantation is a commonly 
implemented therapy for the management of hematologic 
malignancies, hemoglobinopathies, and selective autoimmune 
disorders, and GVHD is considered to be a major limitation to the 
success of the transplant procedure. 
GVHD occurs as a result of the infusion of immunocompetent 
donor T cells into the patient who is immunocompromised as a result 
of reconditioning, total body irradiation, and high dose chemotherapy. 
This results in a cascade of complex processes that include CD8+ and 
CD4+ T cell differentiation and activation, recognition of major and 
minor histocompatibility antigens, and the liberation of a number of 
cytokines and interleukins in various stages including INF-α, IL1 and 
IL2 among others. This ultimately results in the formation of natural 
killer T cells and cytotoxic T cells, the latter being responsible for 
damage of many of the host’s internal organs including the liver, 
gastrointestinal tract, skin, and mucous membranes [2–5]. 
The acute type of GVHD is observed within the first 21 days to 
3 months after BMT and is seen in approximately 75% of transplanted 
patients. Acute GVHD is characterized by TH-1 type cytokine 
production pattern with skin, liver, and gastrointestinal lesions, and is 
caused by cytotoxic T cells and NK cells. In comparison, the chronic 
form of GVHD is characterized by TH-2 type cytokine production with 
systemic manifestations and autoimmune disease type features and 
behavior. Chronic GVHD is seen in approximately 25% of BMT 
survivors and it usually takes place 3 months after the BMT. Acute and 
chronic GVHD also differ in their clinical and histomorphologic 
presentation [3, 6–9]. Acute GVHD may initially present with 
nonspecific signs and symptoms including fever, malaise, and faint 
facial rash that rapidly spreads as a morbilliform maculopapular rash 
to other areas, especially the palms and soles. This is accompanied by 
watery diarrhea, jaundice, and hepatomegaly with elevation of liver 
enzyme profiles. It can also present with more severe, toxic epidermal 
necrolysis—like features. Chronic GVHD, on the other hand, is usually 
characterized by systemic involvement of the eyes, esophagus, liver, 
muscle, genitalia, skin, as well as the central and peripheral nervous 
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systems. Rarely seen are features similar to lichen planus, 
scleroderma and discoid lupus [2, 3, 5, 7, 9]. 
Tremendous overlap exists between the histomorphological 
presentation of acute and chronic GVHD, demonstrating lichen planus-
like features with focal or diffuse basal cell hydropic change, apoptotic 
and dyskeratotic changes in all layers of epithelium, with closely 
associated lymphocytes and cytoid bodies. A paucicellular, 
predominantly chronic inflammatory cell infiltrate that may contain 
patchy neutrophilic and eosinophilic components is seen in the lamina 
propria. The acute lesions may also show, at least in early stages, 
lichen planus-like features but more scarring in the later or 
“sclerodermatous” phase of the disease [3, 5, 6]. 
With the advances in hematopoietic stem cell transplantation in 
the last two decades, the validity of the criteria of separation between 
chronic and acute GVHD was questioned since the separation was 
more or less arbitrary. The acute form may persist beyond 3 months in 
patients receiving reduced-intensity conditioning and the 
manifestations of acute and chronic GVHD can be present 
simultaneously. This generated the current consensus by the NIH that 
clinical manifestations, not the time of onset of symptoms following 
the transplant, is what determines if GVHD is acute or chronic [3, 5, 
9]. 
Oral involvement is seen in 33–50% and 60–80% of acute and 
chronic GVHD, respectively. Lesions may vary in clinical presentation, 
spectrum, and severity, ranging from simple, punctate granular 
erythema with mucosal atrophy to superficial, widespread ulceration to 
reticular and erosive lichen planus-like and scleroderma—like features. 
The oral lesions of GVHD may also appear as bulla and vesicles and 
should therefore be distinguished from other entities that occur in this 
region. The salivary gland tissue also exhibits Sjogrens syndrome-like 
features histologically, such as periductal and perivascular lymphocytic 
or mixed mononuclear inflammatory cell aggregates. Careful and 
prolonged follow-up is necessary since there is a well-documented risk 
of transformation to oral squamous cell carcinoma with more than 64 
cases reported in the last 30 years [2, 5, 6, 9]. 
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In conclusion, the present case represents a well-documented 
example of oral GVHD that occurred in a patient with AML. The exact 
time of onset of these lesions was difficult to determine but her oral 
complaints were brought to the attention of her clinicians after forty 
8 months of the initial bone marrow transplant procedure. Currently, 
her oral lesions remain well controlled with topical prednisone rinse 
and she will also remain under careful clinical follow-up. Additional 
biopsies will be taken in 6 months to exclude any possible dysplastic 
changes which are well documented in oral GVHD lesions. 
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